ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM

ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM

Efficiency of the multiple myeloma treatment with chemotherapy including bortezomib was assessed based on determination of the level of immunoglobulin free light chains in blood serum. The method enables estimation of changes in kinetic parameters of the residual tumor, detection of the disease cour...

Full description

Saved in:
Bibliographic Details
Published in:Alʹmanakh klinicheskoĭ medit͡s︡iny no. 29; pp. 33 - 37
Main Authors: Мitina, T. A., Golenkov, A. K., Baryshnikov, A. Yu, Karaulov, A. V., Trifonova, E. V., Chernykh, Yu. B., Katayeva, E. V., Lutskaya, T. D., Vysotskaya, L. L., Dudina, G. A., Zacharov, S. G., Fomin, A. M., Lyubimova, N. V., Kogarko, I. N.
Format: Journal Article
Language:English
Russian
Published: MONIKI 11-02-2016
Subjects:
bortezomib
free light chains
multiple myeloma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Efficiency of the multiple myeloma treatment with chemotherapy including bortezomib was assessed based on determination of the level of immunoglobulin free light chains in blood serum. The method enables estimation of changes in kinetic parameters of the residual tumor, detection of the disease course prognosis, and the choice of the optimal approach to the disease therapy.
ISSN:2072-0505
2587-9294
DOI:10.18786/2072-0505-2013-29-33-37